INTERCEPT PHARMACEUTICALS IN's ticker is ICPT and the CUSIP is 45845P108. A total of 152 filers reported holding INTERCEPT PHARMACEUTICALS IN in Q2 2022. The put-call ratio across all filers is 0.31 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $303,787 | +18.5% | 22,620 | +9.2% | 0.02% | +11.8% |
| Q4 2022 | $256,344 | -7.5% | 20,723 | +4.5% | 0.02% | -5.6% |
| Q3 2022 | $277,000 | -9.8% | 19,838 | -10.9% | 0.02% | +12.5% |
| Q2 2022 | $307,000 | +8.9% | 22,260 | +28.2% | 0.02% | +6.7% |
| Q1 2022 | $282,000 | +24.8% | 17,360 | +25.1% | 0.02% | +7.1% |
| Q4 2021 | $226,000 | -27.8% | 13,874 | -11.4% | 0.01% | -17.6% |
| Q2 2021 | $313,000 | +7.9% | 15,664 | +24.7% | 0.02% | 0.0% |
| Q1 2021 | $290,000 | – | 12,563 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Samsara BioCapital, LLC | 640,688 | $9,514,000 | 1.49% |
| CM Management, LLC | 45,000 | $668,000 | 0.50% |
| EULAV Asset Management | 660,000 | $9,801,000 | 0.26% |
| DLD Asset Management, LP | 225,200 | $3,346,000 | 0.24% |
| Virtus ETF Advisers LLC | 21,387 | $318,000 | 0.14% |
| GSA CAPITAL PARTNERS LLP | 79,145 | $1,175,000 | 0.12% |
| Hennion & Walsh Asset Management, Inc. | 136,720 | $2,030,000 | 0.11% |
| ALTRINSIC GLOBAL ADVISORS LLC | 168,800 | $2,507,000 | 0.08% |
| Inspire Investing, LLC | 31,868 | $473,000 | 0.06% |
| DUALITY ADVISERS, LP | 51,196 | $760,000 | 0.06% |